Rosiglitazone may increase the risk of chronic heart failure (HF) in patients receiving insulin for type 2 diabetes mellitus

By  

Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Treatment with rosiglitazone reduces ambulatory BP and increases insulin sensitivity in patients with hypertension and type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Effects of Rosiglitazone and Pioglitazone Combined with Metformin on the Prothrombotic State of Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

By Derosa G   D'Angelo A   Ragonesi PD   Ciccarelli L   Piccinni MN   Pricolo F   Salvadeo S   Montagna L   Gravina A   Ferrari I   Galli S   Paniga S   Cicero AFG  

The Journal of International Medical Research, Vol. 34, Iss. 5, 2006-09 ,pp. : 545-555

Field House Publishing

Access to resources Recommend Favorite

Rosiglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus

By Wagstaff A.J.   Goa K.L.  

Drugs, Vol. 62, Iss. 12, 2002-01 ,pp. : 1805-1837

Adis International

Access to resources Recommend Favorite

Rosiglitazone: A Review of its Use in Type 2 Diabetes Mellitus

By Deeks Emma D.   Keam Susan J.  

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2747-2779

Adis International

Access to resources Recommend Favorite